Han-Chung Wu

27PUBLICATIONS
54CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 17, 2026
Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral Protein Degradation.

|May 20, 2026
Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma.

|Mar 04, 2026
Engineering CAR T cells to secrete VEGF-neutralizing scFvs enhances antitumor activity against solid tumors.

Torahito A Gao, Ryan M Shih, Justin D Clubb

|Nov 11, 2025
Technological advancements in antibody-based therapeutics for treatment of diseases.

Ruei-Min Lu, Hsiao-Ling Chiang, Joyce Pei-Yi Yuan

|Sep 10, 2024
Current landscape of mRNA technologies and delivery systems for new modality therapeutics.

Ruei-Min Lu, Hsiang-En Hsu, Ser John Lynon P Perez

|Jul 27, 2024
Multivalent mRNA Vaccine Elicits Broad Protection against SARS-CoV-2 Variants of Concern.

Monika Kumari, Kang-Hao Liang, Shih-Chieh Su

Pageof 5

Frequent Collaborators

3 joint publications

Kang-Hao Liang

3 joint publications

Ruei-Min Lu

2 joint publications

Justin D Clubb

2 joint publications

Yvonne Y Chen